Uwe A. Wittel - Concepedia

Author

Uwe A. Wittel

University Medical Center Freiburg ORCID

Also Known As

Stefan Fichtner-Feigl, U A Wittel, U Wittel, U. A. Wittel, U. Wittel, U.A. Wittel, Ulrich Theodor Hopt, Ulrich Wellner, Uwe A Wittel, Uwe A. Wittel

178

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Freiburg University of Freiburg Heidelberg University University of Nebraska Medical Center University of Lübeck

About

Uwe A. Wittel is an author at University Medical Center Freiburg specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	26	1.2K
2	Health Sciences	2	2	118
3	Engineering	1	1	62
4	Biochemistry	1	1	11
5	Biomolecular Engineering	1	1	11

Uwe A. Wittel

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA) Jony van Hilst, Thijs de Rooij, Sjors Klompmaker, Annals of Surgery	2017	271
Updated Alternative Fistula Risk Score (ua-FRS) to Include Minimally Invasive Pancreatoduodenectomy Timothy H. Mungroop, Sjors Klompmaker, Ulrich F. Wellner, Annals of Surgery	2019	185
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial Markus K. Diener, Felix J. Hüttner, Meinhard Kieser, The Lancet Chronic PancreatitisPancreatic CancerPartial PancreatoduodenectomyPancreatic SurgerySurgery	2017	166
Outcomes After Minimally-invasive Versus Open Pancreatoduodenectomy Sjors Klompmaker, Jony van Hilst, Ulrich F. Wellner, Annals of Surgery	2018	155
Chronic Pancreatic Inflammation Induced by Environmental Tobacco Smoke Inhalation in Rats Uwe A. Wittel, Krishan K. Pandey, Mahefatiana Andrianifahanana, The American Journal of Gastroenterology	2006	147
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group Thomas Seufferlein, Waldemar Uhl, Marko Kornmann, Annals of Oncology Surgical OncologyPancreatic CancerPhase Ii TrialGastrointestinal OncologyMedicine	2022	146
Pathobiological Implications of MUC16 Expression in Pancreatic Cancer Dhanya Haridas, Subhankar Chakraborty, Moorthy P. Ponnusamy, PLoS ONE OncologyPancreatic CancerMalignant DiseaseMedicinePathology	2011	141
Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for nonresectable locally advanced pancreatic cancer: First results of the CONKO-007 trial. Rainer Fietkau, Michael Ghadimi, Robert Grützmann, Journal of Clinical Oncology Surgical OncologyCancer ManagementGastroenterologyMultimodalitySurgery	2022	108
The role of polymorphonuclear leukocytes and oxygen‐derived free radicals in experimental acute pancreatitis: mediators of local destruction and activators of inflammation Bertram Poch, Frank Gansauge, Bettina Rau, FEBS Letters	1999	99
Perioperative and Long-Term Outcome after Standard Pancreaticoduodenectomy, Additional Portal Vein and Multivisceral Resection for Pancreatic Head Cancer Birte Kulemann, Jens Hoeppner, Uwe A. Wittel, Journal of Gastrointestinal Surgery Surgical OncologyPancreatic CancerMedicineHepatobiliary TumorAdditional Portal Vein	2015	84

Page 1